Abstract
ABSTRACTHealthy blood vessels supply neurons to preserve metabolic function. In blinding ischemic proliferative retinopathies (PRs), pathological neovascular tufts often emerge in lieu of needed physiological neuroretina revascularization. We show that metabolic shifts in the neurovascular niche define this angiogenic dichotomy between healthy and diseased blood vessel growth. Fatty acid oxidation (FAO) metabolites accumulated in human and murine retinopathy samples. Neovascular tufts with a distinct single-cell transcriptional signature highly expressed FAO enzymes. The deletion ofSirt3, an FAO regulator, shifted the neurovascular niche metabolism from FAO to glycolysis and suppressed tuft formation. This metabolic transition increasedVegfexpression in astrocytes and reprogrammed pathological EC to a physiological phenotype, hastening vascular regeneration of the ischemic retina. Our findings identify SIRT3 as a metabolic switch in the neurovascular niche, offering a new therapeutic target for optimizing ischemic tissue revascularization.HighlightsPathological EC favor FAO over glycolysis.Unique signature for pathological EC found in proliferative retinopathy model.Sirt3deletion shifts astrocytes and EC metabolism from FAO to glycolysis.Metabolic reprogramming of the vascular niche enhances physiological revascularization.Graphical Abstract
Publisher
Cold Spring Harbor Laboratory